Hims & Hers stock falls after online subscriber revenue declines 5.9% year over year

Traders Union
All News
Financial News
Hims & Hers drops 4.14% today

Highlights

Hims & Hers Health posted an adjusted Q1 2026 loss of $0.18 per share versus a prior-year $0.20 profit, signaling deteriorating earnings momentum.
Monthly online revenue per average subscriber fell 5.9% year-over-year to $80, but FY revenue guidance was raised to $2.8–3.0 billion despite short-term margin pressure.
Technical signals are mixed with price trading below key moving averages; short-term range is likely $25.82 to $29.74, with a 53% probability of further downside.

Earnings reversal and revenue forecast boost drive sentiment shift

Hims & Hers Health reported an adjusted loss per share of 18 cents for the first quarter of 2026, marking a significant reversal from the prior year's 20 cent profit and contributing to increased attention on the company's near-term earnings momentum. The company also disclosed a 5.9% year-over-year decrease in monthly online revenue per average subscriber to $80, largely attributed to operational changes in shipping cadence for certain products. Despite these setbacks, Hims & Hers Health raised its full-year revenue projection to between $2.8 billion and $3 billion, reflecting confidence in top-line growth even as short-term earnings come under pressure.

Divergent technical signals as momentum remains mixed near support

On the H1 timeframe, HIMS is trading below the MA-20 and above the MA-50, while on the daily chart it remains below the MA-200. The Ichimoku Kijun is positioned at $27.58, currently acting as immediate support. RSI stands at 49.99 and is labeled as Sell, while Stoch RSI and CCI remain neutral, indicating the absence of strong momentum signals. MACD issues a Strong Buy, in contrast to a neutral ADX, highlighting a divergence in momentum indicators. Bull/Bear Power signals intraday seller dominance and the Awesome Oscillator is neutral.

Volatility expected as range-bound trade weighs on direction

In the short term, HIMS is expected to remain volatile within the $25.82 to $29.74 range, reflecting the current volatility band relative to recent levels. Statistical models show a 53% probability of further downside and a 47% probability of an upward move. The baseline scenario suggests the stock trades within this range as buyers and sellers seek direction. A break above resistance could trigger a bullish move, while sustained trading below key support may intensify selling pressure.

Anton Kharitonov, expert at Traders Union, sees clear warning signs on both technical and fundamental fronts. He notes that the recent shift from profit to loss, coupled with a decline in revenue per subscriber, adds pressure to sentiment. HIMS is trading below key short-term averages and momentum remains mixed, leaving the bias tilted to the downside unless buyers reclaim control. "Base case remains volatile within $25.82 to $29.74 – no reason to expect a sustainable turnaround at this stage."

Earlier, analysts noted that Hims & Hers Health was exhibiting medium-term bullish momentum despite signals of short-term overextension and longer-term resistance. With the latest earnings-driven declines and a shift in technical momentum, traders should closely monitor whether the stock can maintain support above the Ichimoku Kijun at $27.58, as a sustained break below this level could accelerate downside risk in the days ahead.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.